DCF — BROWARD HEALTH NORTH
Enterprise Value: $-658.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-658.3M
Enterprise Value
$-203.2M
PV of Cash Flows
$-455.1M
PV of Terminal Value
$-732.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $261.7M | $-43.8M | -17.0% | $-54.8M | $-49.9M |
| Year 2 | $269.6M | $-42.4M | -16.0% | $-53.8M | $-44.5M |
| Year 3 | $277.6M | $-40.9M | -15.0% | $-52.6M | $-39.5M |
| Year 4 | $286.0M | $-40.7M | -14.0% | $-52.8M | $-36.0M |
| Year 5 | $294.6M | $-41.2M | -14.0% | $-53.6M | $-33.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-658.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$254.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.17222563200422994
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5